, France
To meet the demands of the booming synthetic biology market, we need to develop a faster and more affordable DNA synthesis technology than the current market standard which is based on a complex chemical process and that is time-consuming, inefficient, with limited synthesis flexibility and requires toxic chemicals.
Technologie - Deeptech
Technologies
Business model
B2B
Présence
N° Immat:
Secteurs cibles
Santé / Pharma / Médecine
Métiers cibles
Partenariat(s) recherché(s)
Partenaires